Deprecated: The each() function is deprecated. This message will be suppressed on further calls in /home/zhenxiangba/zhenxiangba.com/public_html/phproxy-improved-master/index.php on line 456
HRP20100029T1 - Novi kristalinični anhidrid s antiholinergičkim učinkom - Google Patents
[go: Go Back, main page]

HRP20100029T1 - Novi kristalinični anhidrid s antiholinergičkim učinkom - Google Patents

Novi kristalinični anhidrid s antiholinergičkim učinkom Download PDF

Info

Publication number
HRP20100029T1
HRP20100029T1 HR20100029T HRP20100029T HRP20100029T1 HR P20100029 T1 HRP20100029 T1 HR P20100029T1 HR 20100029 T HR20100029 T HR 20100029T HR P20100029 T HRP20100029 T HR P20100029T HR P20100029 T1 HRP20100029 T1 HR P20100029T1
Authority
HR
Croatia
Prior art keywords
cyclodextrin
tiotropium bromide
medicine
anhydride
crystalline
Prior art date
Application number
HR20100029T
Other languages
English (en)
Croatian (hr)
Inventor
Pfrengle Waldemar
Sieger Peter
Original Assignee
Boehringer Ingelheim International Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34530662&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HRP20100029(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim International Gmbh filed Critical Boehringer Ingelheim International Gmbh
Publication of HRP20100029T1 publication Critical patent/HRP20100029T1/hr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • C07D451/06—Oxygen atoms
    • C07D451/10—Oxygen atoms acylated by aliphatic or araliphatic carboxylic acids, e.g. atropine, scopolamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pulmonology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HR20100029T 2003-11-03 2004-10-29 Novi kristalinični anhidrid s antiholinergičkim učinkom HRP20100029T1 (hr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03025077 2003-11-03
PCT/EP2004/012269 WO2005042527A1 (de) 2003-11-03 2004-10-29 Neues kristallines anhydrat mit anticholinerger wirksamkeit

Publications (1)

Publication Number Publication Date
HRP20100029T1 true HRP20100029T1 (hr) 2010-02-28

Family

ID=34530662

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20100029T HRP20100029T1 (hr) 2003-11-03 2004-10-29 Novi kristalinični anhidrid s antiholinergičkim učinkom

Country Status (33)

Country Link
EP (1) EP1682542B1 (sr)
JP (1) JP4553902B2 (sr)
KR (2) KR101313904B1 (sr)
CN (1) CN100509809C (sr)
AR (1) AR046319A1 (sr)
AT (1) ATE453641T1 (sr)
AU (1) AU2004285684B2 (sr)
BR (1) BRPI0415636A (sr)
CA (1) CA2544352C (sr)
CO (1) CO5690641A2 (sr)
CY (1) CY1110339T1 (sr)
DE (1) DE502004010602D1 (sr)
DK (1) DK1682542T3 (sr)
EA (1) EA008587B1 (sr)
EC (1) ECSP066543A (sr)
ES (1) ES2338563T3 (sr)
HR (1) HRP20100029T1 (sr)
IL (1) IL175126A (sr)
ME (1) ME00349B (sr)
MX (1) MX272045B (sr)
MY (1) MY146628A (sr)
NO (1) NO20062569L (sr)
NZ (1) NZ547581A (sr)
PE (1) PE20050996A1 (sr)
PL (1) PL1682542T3 (sr)
PT (1) PT1682542E (sr)
RS (2) RS51599B (sr)
SI (1) SI1682542T1 (sr)
TW (1) TWI336330B (sr)
UA (1) UA82909C2 (sr)
UY (1) UY28596A1 (sr)
WO (1) WO2005042527A1 (sr)
ZA (1) ZA200602344B (sr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008540367A (ja) * 2005-05-02 2008-11-20 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 新規結晶性臭化チオトロピウム
US9108962B2 (en) 2005-12-19 2015-08-18 Sicor, Inc. Forms of tiotropium bromide and processes for preparation thereof
US8163913B2 (en) 2005-12-19 2012-04-24 Sicor Inc. Forms of tiotropium bromide and processes for preparation thereof
RU2453547C2 (ru) * 2005-12-19 2012-06-20 Сикор Инк. Новые формы тиотропия бромида и способы их получения
DK1971332T3 (da) * 2006-01-04 2011-04-18 Boehringer Ingelheim Int Anvendelse af tiotropium-salte til behandling af moderat vedvarende astma
CN100999521B (zh) * 2006-01-13 2010-12-08 江苏正大天晴药业股份有限公司 结晶性抗胆碱药噻托溴铵
US20080051582A1 (en) 2006-07-10 2008-02-28 Sicor Inc. Process for the preparation of tiotropium bromide
CN101032484B (zh) * 2007-04-02 2010-05-26 南京卡文迪许生物工程技术有限公司 一种噻托溴铵胶囊型吸入粉雾剂
GB0716026D0 (en) 2007-08-16 2007-09-26 Norton Healthcare Ltd An inhalable medicament
CA2742356A1 (en) * 2008-11-04 2010-05-14 Cipla Limited Tiotropium bromide having a low degree of crystallinity
KR20110096538A (ko) * 2008-11-04 2011-08-30 씨아이피엘에이 엘티디. 약제학적 에어로졸 조성물
NZ597920A (en) * 2009-08-07 2014-05-30 Generics Uk Ltd Anhydrate of tiotropium bromide
TR201111589A2 (tr) * 2011-03-03 2012-09-21 Bi̇lgi̇ç Mahmut Tiotropyum bromür susuz kristal formu.
CZ304368B6 (cs) 2011-11-28 2014-04-02 Zentiva, K.S. Směsný solvát tiotropium bromidu a způsob jeho přípravy
GB201200525D0 (en) 2011-12-19 2012-02-29 Teva Branded Pharmaceutical Prod R & D Inc An inhalable medicament
WO2014042605A1 (en) * 2012-09-11 2014-03-20 Mahmut Bilgic New tiotropium bromide crystalline form
PT2914593T (pt) 2012-11-05 2017-04-03 Zentiva Ks Estabilização de solvatos de tiotrópio
EP2913332A1 (en) 2014-02-27 2015-09-02 Euticals S.P.A. Crystalline form of tiotropium bromide with lactose
US10034866B2 (en) 2014-06-19 2018-07-31 Teva Branded Pharmaceutical Products R&D, Inc. Inhalable medicament comprising tiotropium
WO2017138896A1 (en) 2016-02-11 2017-08-17 Sima Patent Ve Lisanslama Hizmetleri Ltd. Şti Crystalline form of tiotropium bromide anhydrate
EP4108230A1 (en) 2021-06-24 2022-12-28 Laboratoires SMB New dry powder composition of tiotropium for inhalation

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3931041C2 (de) * 1989-09-16 2000-04-06 Boehringer Ingelheim Kg Ester von Thienylcarbonsäuren mit Aminoalkoholen, ihre Quaternierungsprodukte, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
US5610163A (en) * 1989-09-16 1997-03-11 Boehringer Ingelheim Gmbh Esters of thienyl carboxylic acids and amino alcohols and their quaternization products
WO2002030928A1 (de) * 2000-10-12 2002-04-18 Boehringer Ingelheim Pharma Gmbh & Co. Kg Kristallines monohydrat, verfahren zu dessen herstellung und dessen verwendung zur herstellung eines arzneimittels
DE10111843A1 (de) * 2001-03-13 2002-09-19 Boehringer Ingelheim Pharma Verbindungen zur Behandlung von inflammatorischen Erkrankungen
ME00412B (me) * 2001-06-22 2011-10-10 Boehringer Ingelheim Pharma Kristalni antiholinergik , postupak za njegovo pripremanje i njegova primjena u proizvodnji lijeka

Also Published As

Publication number Publication date
TW200526652A (en) 2005-08-16
RS51599B (sr) 2011-08-31
PL1682542T3 (pl) 2010-06-30
CA2544352A1 (en) 2005-05-12
AR046319A1 (es) 2005-11-30
ECSP066543A (es) 2006-10-17
EA008587B1 (ru) 2007-06-29
MEP51708A (en) 2011-02-10
ZA200602344B (en) 2007-07-25
KR20060121131A (ko) 2006-11-28
ES2338563T3 (es) 2010-05-10
CY1110339T1 (el) 2015-01-14
ME00349B (me) 2011-05-10
WO2005042527A1 (de) 2005-05-12
CO5690641A2 (es) 2006-10-31
ATE453641T1 (de) 2010-01-15
PE20050996A1 (es) 2005-12-20
IL175126A0 (en) 2006-09-05
AU2004285684B2 (en) 2011-07-14
SI1682542T1 (sl) 2010-04-30
UA82909C2 (en) 2008-05-26
AU2004285684A1 (en) 2005-05-12
UY28596A1 (es) 2005-06-30
CN1875019A (zh) 2006-12-06
TWI336330B (en) 2011-01-21
KR101313904B1 (ko) 2013-09-30
MY146628A (en) 2012-09-14
CA2544352C (en) 2013-07-16
IL175126A (en) 2010-11-30
KR20120036381A (ko) 2012-04-17
EP1682542A1 (de) 2006-07-26
MXPA06004940A (es) 2006-07-20
JP4553902B2 (ja) 2010-09-29
EP1682542B1 (de) 2009-12-30
KR101285571B1 (ko) 2013-07-15
DK1682542T3 (da) 2010-05-10
NO20062569L (no) 2006-07-12
PT1682542E (pt) 2010-01-27
RS20060291A (sr) 2008-06-05
DE502004010602D1 (de) 2010-02-11
NZ547581A (en) 2009-03-31
HK1099752A1 (zh) 2007-08-24
BRPI0415636A (pt) 2006-12-12
MX272045B (en) 2009-11-23
CN100509809C (zh) 2009-07-08
JP2007509894A (ja) 2007-04-19
EA200600853A1 (ru) 2006-10-27

Similar Documents

Publication Publication Date Title
HRP20100029T1 (hr) Novi kristalinični anhidrid s antiholinergičkim učinkom
US5756483A (en) Pharmaceutical compositions for intranasal administration of apomorphine
ES2987493T3 (es) Comprimido oral desintegrable de edoxaban tosilato hidrato
JP6054940B2 (ja) １−（３−（２−（１−ベンゾチオフェン−５−イル）エトキシ）プロピル）アゼチジン−３−オールまたはその塩を含有する固形医薬組成物
RU2010124424A (ru) Фармацевтические композиции
PT998916E (pt) Composições medicamentosas para aplicação sobre as mucosas
NZ547523A (en) Novel tiotropium salts, methods for the production thereof, and pharmaceutical formulations containing the same
CN104000789A (zh) 一种阿德福韦酯分散片及其制备方法
WO2017077476A1 (en) Novel levothyroxine formulations for oral use
TWI826474B (zh) 包含二胺衍生物之顆粒劑、以及其用途及製造方法
CA2827299A1 (en) Liquid propellant-free formulation comprising an antimuscarinic drug
EP2566449B1 (en) Pharmaceutical compositions comprising ceftibuten
CN106361689A (zh) 一种福多司坦口服溶液及其制备方法
ES2343432T3 (es) Preparado granular que contiene un compuesto de biguanida.
CN104523631A (zh) 一种治疗抑郁症的奥氮平口腔崩解片的制备方法
RU2004132222A (ru) Порошковые композиции, пригодные для ингаляции
KR100957731B1 (ko) 쓴맛이 저감된 프란루카스트 수화물을 함유하는 제제
PT97491B (pt) Processo para a preparacao de uma composicao farmaceutica, contendo nomeadamente um antibiotico beta-lactamico
JP2005526103A5 (sr)
JP6112696B1 (ja) ソリスロマイシンを含む錠剤
WO2011139251A1 (en) Pharmaceutical compositions comprising cefditoren pivoxil
JP3899522B2 (ja) 苦味が低減されたプランルカスト水和物を含有する製剤
JP2001187735A (ja) 安定なニコランジル含有粉末の製造法
JP2018035132A (ja) 乾式造粒物及び該乾式造粒物を含有する固形製剤並びにそれらの製造方法
ES2694710T3 (es) Comprimidos que comprenden un agente que enmascara el sabor